INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![GettyImages-1200984194 elderly mobility]( "Tailored Solutions For A Global Phase III Neovascular AMD Study")
Tailored Solutions For A Global Phase III Neovascular AMD StudyHow did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?
-
![Panel Discussion]( "Harnessing The Potential Of Patient-Level Data In Clinical Trials")
Harnessing The Potential Of Patient-Level Data In Clinical TrialsJoin our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
-
![GettyImages-1318863581 patient travel]( "Eliminating Travel As A Top Barrier To Clinical Trial Participation")
Eliminating Travel As A Top Barrier To Clinical Trial ParticipationParticipant travel is an area consistently cited as a leading barrier to participation. Here, the author highlights several examples of unique challenges encountered by participants and how Greenphire worked to eliminate them.
-
![GettyImages-2163190867-hospital-doctor-administrator-discussion]( "Rethinking Clinical Operations: A Smarter, Faster Playbook For Trial Success")
Rethinking Clinical Operations: A Smarter, Faster Playbook For Trial SuccessThe CRO-sponsor partnership is now strategic, addressing communication gaps and fragmented systems to improve efficiency. Joint governance, real-time tracking, and unified technology accelerate complex trial execution.
-
Central eSource Is The Latest In Sponsor Provided Site Offerings7/7/2025
For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.
-
EHR-To-EDC: Choosing The Right Solution For Clinical Trials12/13/2024
Here we highlight key advantages of EHR-to-EDC eSource, such as cost-effectiveness and improved site satisfaction.
-
The Greatest Impact Of Tax In Clinical Research5/15/2024
In a recent Site Survey, Greenphire collected site perspectives on taxation in clinical trials and its impact on participants. Here, we review several real-life examples that were shared by survey participants.
-
Key Strategies For Clinical Development In Rare Cancers2/11/2025
Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.
-
The Power Of AI To Improve Clinical Trial Monitoring4/11/2025
By analyzing patient data sets, AI enhances predictive analytics, supports real-time patient alerts, and strengthens continuous monitoring — improving the effectiveness of clinical trial oversight.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![Hand holding magnifier glass hiring recruit]( "Patient Recruitment And Site Selection")
Novotech relies on years of experience, in-country knowledge, and real-life big data to identify and propose the best-performing sites. Uncover the possibilities for your next study.
-
![ESG_Getty-1398247435]( "PCI Pharma Services ESG Report")
Review PCI's commitment to environmental and social responsibility, including its ambitious sustainability goals and achievements across various categories.
-
![GettyImages-1483251775-scientists-computer-analysis]( "Simplify Your Sites Operations, Patient Payments, Travel, And Logistics")
Simplify patient support in clinical trials through comprehensive expense management, travel coordination, and site services designed to reduce the burden on sites and participants.
-
![manufacturing]( "Powder Blending And Encapsulation Services")
Ropack Pharma Solutions recognizes the significance of manufacturing in generating pharmaceutical and nutraceutical products which meet the highest standards. With precision as our goal, we offer blending and encapsulation services in cGMP-compliant facilities utilizing gold-standard technology.
-
![rare diagnosis GettyImages-1368429047]( "Rare Disease Center Of Excellence Overcomes Unique Obstacles")
Biorasi’s Beeline platform provides clinical teams with unique, real-time transparency for quick responses to rare and urgent disease trial challenges.
